
Section
Manufacturing
Capacity, CDMO strategy, inspections, supply bottlenecks, and manufacturing constraints that shape commercial reality.
18 articles · Last updated

Manufacturing· June 15, 2026 · 11 min read

Manufacturing· June 14, 2026 · 10 min read
Anesthesia injectable shortage: 342 records, 99 not fully available, 8-year median

Manufacturing· June 14, 2026 · 11 min read
The oncology injectable shortage, in data: carboplatin and 18 chemo molecules

Manufacturing· June 13, 2026 · 14 min read
FDA drug shortage list: reading status, reason, and presentation fields

Manufacturing· June 10, 2026 · 9 min read
Who supplies the world's essential medicines: 1,139 WHO-PQ products, 59% from India

Manufacturing· June 9, 2026 · 6 min read
The commercial ecosystem behind cell & gene therapy: ASGCT 2026 exhibitors mapped

Manufacturing· May 22, 2026 · 10 min read
Analytical Method Transfer Acceptance Criteria for a New Release-Testing Lab
By Ran Chen#CMC#FDA#Regulatory

Manufacturing· May 22, 2026 · 13 min read
API supplier change control: DMF letter-of-authorization and notification traps

Manufacturing· May 22, 2026 · 10 min read
CDMO quality agreement red flags that become FDA inspection findings
By Ran Chen#Manufacturing Capacity#CMC#FDA Approval

Manufacturing· May 22, 2026 · 14 min read
CMC-only complete response letters: how commercial teams should read the risk
By Ran Chen#Manufacturing Capacity#CMC#FDA Approval